Qube Research & Technologies (QRT)
GSK icon

Qube Research & Technologies (QRT)’s GSK GSK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-400
Closed -$15.5K – 3703
2025
Q1 		$15.5K Hold
400
– – ﹤0.01% 3244
2024
Q4 		$13.5K Buy
+400
New +$14.4K ﹤0.01% 3218

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GSK Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its GSK (GSK) stake by 97% in Q2 2026, buying an estimated $28.1M and bringing the position to 1,078,767 shares worth $56.5M. The position accounts for 0.05% of the portfolio, ranked #457.

Qube Research & Technologies (QRT) first reported a position in GSK in Q1 2018 and has held it in 17 quarters since. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,078,767 shares of GSK worth $56.5M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 530,545 GSK shares in Q2 2026, an estimated $28.1M.
  • GSK made up 0.05% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #457 holding.
  • Qube Research & Technologies (QRT) first reported a position in GSK in Q1 2018 and has held it in 17 quarters since.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.